State Of Alaska, Department Of Revenue Harrow Health, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.79 Billion
- Q3 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Harrow Health, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 1,742 shares of HROW stock, worth $72,293. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,742Holding current value
$72,293% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
183Shares Held
21.6MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$162 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$89.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$80.7 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$77.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$36.2 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.12B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...